PL352683A1 - Kompozycja do zapobiegania zmęczeniu mięśni i do przystosowania mięśni szkieletowych do ćwiczesigmaforsownych - Google Patents
Kompozycja do zapobiegania zmęczeniu mięśni i do przystosowania mięśni szkieletowych do ćwiczesigmaforsownychInfo
- Publication number
- PL352683A1 PL352683A1 PL00352683A PL35268300A PL352683A1 PL 352683 A1 PL352683 A1 PL 352683A1 PL 00352683 A PL00352683 A PL 00352683A PL 35268300 A PL35268300 A PL 35268300A PL 352683 A1 PL352683 A1 PL 352683A1
- Authority
- PL
- Poland
- Prior art keywords
- prevention
- composition
- muscle
- adaptation
- strenuous exercise
- Prior art date
Links
- 206010049565 Muscle fatigue Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 230000011667 skeletal muscle adaptation Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT1999RM000467A IT1306173B1 (it) | 1999-07-23 | 1999-07-23 | Composizione per la prevenzione degli affaticamenti muscolari e permigliorare il rendimento energetico muscolare. |
PCT/IT2000/000308 WO2001006873A1 (en) | 1999-07-23 | 2000-07-21 | Composition for the prevention of muscle fatigue and skeletal muscle adaptation to strenuous exercise |
Publications (2)
Publication Number | Publication Date |
---|---|
PL352683A1 true PL352683A1 (pl) | 2003-09-08 |
PL204743B1 PL204743B1 (pl) | 2010-02-26 |
Family
ID=11406897
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL352683A PL204743B1 (pl) | 1999-07-23 | 2000-07-21 | Kompozycja farmaceutyczna do podawania doustnego, pozajelitowego, doodbytniczego lub przezskórnego i zastosowanie kompozycji do wytwarzania leku i dietetycznego środka spożywczego |
Country Status (21)
Country | Link |
---|---|
US (1) | US6602512B1 (pl) |
EP (1) | EP1196046B1 (pl) |
AR (1) | AR024820A1 (pl) |
AT (1) | ATE263496T1 (pl) |
AU (1) | AU778647B2 (pl) |
CA (1) | CA2377128C (pl) |
CZ (1) | CZ20023A3 (pl) |
DE (1) | DE60009704T2 (pl) |
DK (1) | DK1196046T3 (pl) |
ES (1) | ES2216931T3 (pl) |
HU (1) | HU228838B1 (pl) |
IL (1) | IL147408A0 (pl) |
IT (1) | IT1306173B1 (pl) |
MX (1) | MXPA02000780A (pl) |
NO (1) | NO20020337L (pl) |
PL (1) | PL204743B1 (pl) |
PT (1) | PT1196046E (pl) |
SK (1) | SK942002A3 (pl) |
TN (1) | TNSN00161A1 (pl) |
TR (1) | TR200200179T2 (pl) |
WO (1) | WO2001006873A1 (pl) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1316998B1 (it) * | 2000-03-02 | 2003-05-26 | Sigma Tau Healthscience Spa | Composizione per la prevenzione e/o il trattamento degli effetticitotossici indotti dall'uso di agenti immunosoppressori. |
US6849613B2 (en) | 2001-08-29 | 2005-02-01 | Kedar N. Prasad | Multiple antioxidant micronutrients |
US7449451B2 (en) * | 2001-08-29 | 2008-11-11 | Premier Micronutrient Corporation | Use of multiple antioxidant micronutrients as systemic biological radioprotective agents against potential ionizing radiation risks |
DE10160485A1 (de) * | 2001-12-08 | 2003-10-02 | Degussa | Verwendung von Kreatin und/oder einem seiner physiologisch geeigneten Derivate zur Prävention oder Linderung von nicht krankheitsbedingten Beeinträchtigungen und/oder Störungen der Muskelfunktion |
DE102004009962A1 (de) * | 2004-03-01 | 2005-09-22 | Degussa Ag | Verwendung von Guanidin-Verbindungen als physiologisches Stärkungsmittel in Form von Nahrungsergänzungsmitteln, Futtermittelzusätzen, in kosmetischen Zubereitungen und als Pflanzenstärkungsmittel |
WO2006034586A1 (en) * | 2004-09-29 | 2006-04-06 | Aplodan Formulations Ltd. | Nutritional composition for promoting muscle performance and acting as hydrogen (h+) blocker |
WO2007006135A1 (en) * | 2005-07-07 | 2007-01-18 | H3 Formulations Ltd. | Dietary supplement for enhancing skeletal muscle mass, decreasing muscle protein degradation, downregulation of muscle catabolism pathways, and decreasing catabolism of muscle cells |
GB0606864D0 (en) * | 2006-04-05 | 2006-05-17 | Univ Nottingham | Increades fatty acid oxidation |
AU2006347819A1 (en) * | 2006-08-30 | 2008-03-06 | Aplodan Formulations Ltd. | Increasing ATP availability by inhibition of Creatine Kinase (CK) leakage resulting from high-intensity exercise |
US7368441B2 (en) * | 2006-08-30 | 2008-05-06 | Aplodan Formulations Ltd. | Method of increasing intracellular concentrations of phosphate and increasing the force of muscular contractions |
WO2008025115A1 (en) * | 2006-08-30 | 2008-03-06 | Aplodan Formulations Ltd. | Method of increasing intracellular concentrations of phosphate and increasing the force of muscular contractions |
US7375097B2 (en) * | 2006-08-30 | 2008-05-20 | Aplodan Formulations Ltd. | Increasing ATP availability by inhibition of creatine kinase (CK) leakage resulting from high-intensity exercise |
US20100124587A1 (en) * | 2008-11-17 | 2010-05-20 | Heuer Marvin A | Creatine-containing vitamin and mineral composition |
US20110105786A1 (en) * | 2009-11-02 | 2011-05-05 | Tianjin Tiancheng Pharmaceutical Co., Ltd. | Creatinol o-phosphate and synthesis method thereof |
TWI489981B (zh) | 2010-12-10 | 2015-07-01 | 柏萊迪健康科學有限責任公司 | 使用茉莉酸治療膀胱功能障礙 |
JP6982956B2 (ja) * | 2014-06-12 | 2021-12-17 | ロンザ・コンシューマー・ヘルス・インコーポレーテッド | 哺乳動物において骨格筋損傷及び/又は酸化ストレスを軽減する方法 |
US10499682B2 (en) | 2014-08-25 | 2019-12-10 | New Age Beverage Corporation | Micronutrient formulation in electronic cigarettes |
EP3368498A4 (en) | 2015-10-27 | 2019-06-12 | Cytozyme Animal Nutrition, Inc. | ANIMAL NUTRITIONAL COMPOSITIONS AND RELATED METHODS |
US10674746B2 (en) | 2015-10-27 | 2020-06-09 | Cytozyme Animal Nutrition, Inc. | Animal nutrition compositions and related methods |
BR112018012410B1 (pt) | 2015-12-18 | 2022-12-20 | Lonza Consumer Health Inc | Composição para o aumento da síntese de proteína e/ou força funcional musculares em mamíferos |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU518617B2 (en) * | 1977-04-29 | 1981-10-08 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Therapeutic application of acetyl-d, 1-carnitine |
IT1124697B (it) | 1979-10-26 | 1986-05-14 | Simes | Derivati di creatinolo o-fosfato ad azione terapeutica,procedimento per la sua preparazione e relativ-e composizioni farmaceutiche |
US6080788A (en) * | 1997-03-27 | 2000-06-27 | Sole; Michael J. | Composition for improvement of cellular nutrition and mitochondrial energetics |
IT1291127B1 (it) | 1997-04-01 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Integratore alimentare per soggetti dediti ad intensa e prolungata attivita' fisica |
EP0891719A1 (en) * | 1997-07-14 | 1999-01-20 | N.V. Nutricia | Nutritional composition containing methionine |
WO1999051097A1 (en) * | 1998-04-02 | 1999-10-14 | Avicena Group, Inc. | Compositions containing a combination of a creatine compound and a second agent |
ES2146555B1 (es) | 1999-01-22 | 2001-03-01 | Helsint S A L | Empleo de formulaciones a base de fracciones hidrosolubles de phlebodium decumanum (exply-37) y/o polypodium leucotomos como complemento nutricional en la prevencion y reversion del sindrome de sobresfuerzo fisico. |
-
1999
- 1999-07-23 IT IT1999RM000467A patent/IT1306173B1/it active
-
2000
- 2000-07-21 AR ARP000103777A patent/AR024820A1/es unknown
- 2000-07-21 IL IL14740800A patent/IL147408A0/xx unknown
- 2000-07-21 AU AU64687/00A patent/AU778647B2/en not_active Ceased
- 2000-07-21 AT AT00951844T patent/ATE263496T1/de active
- 2000-07-21 TR TR2002/00179T patent/TR200200179T2/xx unknown
- 2000-07-21 TN TNTNSN00161A patent/TNSN00161A1/fr unknown
- 2000-07-21 SK SK94-2002A patent/SK942002A3/sk unknown
- 2000-07-21 HU HU0202298A patent/HU228838B1/hu not_active IP Right Cessation
- 2000-07-21 MX MXPA02000780A patent/MXPA02000780A/es active IP Right Grant
- 2000-07-21 US US10/019,546 patent/US6602512B1/en not_active Expired - Lifetime
- 2000-07-21 CZ CZ20023A patent/CZ20023A3/cs unknown
- 2000-07-21 DK DK00951844T patent/DK1196046T3/da active
- 2000-07-21 PL PL352683A patent/PL204743B1/pl unknown
- 2000-07-21 EP EP00951844A patent/EP1196046B1/en not_active Expired - Lifetime
- 2000-07-21 DE DE60009704T patent/DE60009704T2/de not_active Expired - Lifetime
- 2000-07-21 WO PCT/IT2000/000308 patent/WO2001006873A1/en active IP Right Grant
- 2000-07-21 ES ES00951844T patent/ES2216931T3/es not_active Expired - Lifetime
- 2000-07-21 PT PT00951844T patent/PT1196046E/pt unknown
- 2000-07-21 CA CA002377128A patent/CA2377128C/en not_active Expired - Lifetime
-
2002
- 2002-01-22 NO NO20020337A patent/NO20020337L/no unknown
Also Published As
Publication number | Publication date |
---|---|
US6602512B1 (en) | 2003-08-05 |
TR200200179T2 (tr) | 2002-06-21 |
ATE263496T1 (de) | 2004-04-15 |
SK942002A3 (en) | 2002-05-09 |
CA2377128A1 (en) | 2001-02-01 |
ITRM990467A0 (it) | 1999-07-23 |
AU778647B2 (en) | 2004-12-16 |
CZ20023A3 (cs) | 2002-06-12 |
ITRM990467A1 (it) | 2001-01-23 |
IL147408A0 (en) | 2002-08-14 |
EP1196046B1 (en) | 2004-04-07 |
IT1306173B1 (it) | 2001-05-30 |
WO2001006873A1 (en) | 2001-02-01 |
AR024820A1 (es) | 2002-10-23 |
DE60009704D1 (de) | 2004-05-13 |
ES2216931T3 (es) | 2004-11-01 |
DK1196046T3 (da) | 2004-08-02 |
NO20020337D0 (no) | 2002-01-22 |
AU6468700A (en) | 2001-02-13 |
PT1196046E (pt) | 2004-08-31 |
PL204743B1 (pl) | 2010-02-26 |
EP1196046A1 (en) | 2002-04-17 |
NO20020337L (no) | 2002-03-22 |
DE60009704T2 (de) | 2005-04-14 |
HUP0202298A3 (en) | 2005-07-28 |
HU228838B1 (en) | 2013-06-28 |
TNSN00161A1 (fr) | 2005-11-10 |
HUP0202298A2 (en) | 2002-10-28 |
MXPA02000780A (es) | 2002-08-20 |
CA2377128C (en) | 2009-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0202298A3 (en) | Composition for the prevention of muscle fatigue and skeletal muscle adaptation to strenuous exercise | |
EP1005330A4 (en) | METHODS AND COMPOSITIONS FOR TARGETING COMPOUNDS TO MUSCLES | |
AU2003299088A8 (en) | Nocturnal muscle enhancing composition and method | |
GB9724813D0 (en) | Reducing muscle fatigue | |
GB2314782B (en) | Muscle exerciser | |
AU7255198A (en) | Methods and compositions for the prevention and treatment of muscle cramps and improving muscular strength in athletes | |
GB0302882D0 (en) | Improvements in or relating to agents for the treatment of cardiovascular dysfunction and weight loss | |
AU2002360531A8 (en) | Methods and compositions to treat cardiovascular disease using 1419, 58765 and 2201 | |
GB9904667D0 (en) | Hand or foot pedalled exerciser | |
AU1800801A (en) | Exercise and muscle enhancement formulations | |
AU5591700A (en) | Exercise grips attached to shoes | |
GB0020018D0 (en) | Improvements relating to muscle toner pads | |
GB2347871B (en) | Specialised rehabilitation and exercise machine | |
EP1488810A4 (en) | PERCUTANEOUS ABSORPTION PROMOTERS AND COMPOSITIONS FOR TREATING THE FOOT AFTER A SPORT EFFORT | |
TW381501U (en) | Exerciser with multiform of exercise effect | |
TW340388U (en) | Addition 1 to the hip exerciser | |
TW367840U (en) | Palm muscle massager with grip-force training | |
TW353972U (en) | Improvement of batting exerciser for boxer | |
TW328231U (en) | Thigh sporting exerciser | |
TW368880U (en) | Improved wrist strenghtening exercise equipment | |
IL152611A0 (en) | Methods and compositions for the treatment and prevention of smooth muscle cell proliferation | |
GB9909660D0 (en) | Improvements in or relating to sports equipment | |
GB9414711D0 (en) | Improvements to muscle training devices | |
GB9715070D0 (en) | Inspiratory muscle trainer | |
TW351186U (en) | Improvement of exercise walker |